Blocking bone morphogenetic protein function using in vivo noggin therapy does not rescue premature suture fusion in rabbits with delayed-onset craniosynostosis

Plastic and Reconstructive Surgery

Volumn 127, Issue 3, 2011, Pages 1163-1172

  Cray Jr , James ^{a,b,c,d,e,f,g,h}   Burrows, Anne M ^{a,b,c,d,e,f,g,h}   Vecchione, Lisa ^{a,b,c,d,e,f,g,h}   Caccamese, John F ^{a,b,c,d,e,f,g,h}   Losee, Joseph E ^{a,b,c,d,e,f,g,h}   Moursi, Amr M ^{a,b,c,d,e,f,g,h}   Siegel, Michael I ^{a,b,c,d,e,f,g,h}   Cooper, Gregory M ^{a,b,c,d,e,f,g,h}   Mooney, Mark P ^{a,b,c,d,e,f,g,h}  

^a Division of Plastic and Reconstructive Surgery   (United States)

^b Department of Anthropology Orthodontics and Dentofacial Orthopedics ^*  (United States)

^c University of Pittsburgh   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^f DUQUESNE UNIVERSITY   (United States)

^g UNIVERSITY OF MARYLAND   (United States)

^h NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CARRIER PROTEIN; NOGGIN PROTEIN;

ANIMAL; ARTICLE; BONE DEVELOPMENT; CEPHALOMETRY; COMPARATIVE STUDY; CRANIAL SUTURE; CRANIOFACIAL SYNOSTOSIS; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; PATHOLOGY; PHYSIOLOGY; RABBIT;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CARRIER PROTEINS; CEPHALOMETRY; CRANIAL SUTURES; CRANIOSYNOSTOSES; DISEASE MODELS, ANIMAL; OSTEOGENESIS; RABBITS;

EID: 79952751647     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e318205f23b     Document Type: Article

References (70)

1. Bonaventure J, El Ghouzzi V. Molecular and cellular bases of syndromic craniosynostoses. Expert Rev Mol Med. 2003;5:1-17.
2. Cohen M, MacLean R. Craniosynostosis: Diagnosis, Evaluation, and Management. New York: Oxford Press; 2000.
3. Cohen MM Jr. Editorial: Perspectives on craniosynostosis. Am J Med Genet A 2005;136 A: 313-326. (Pubitemid 41076578)
4. Mooney M, Richtmeier J. Cranial sutures and calvaria: Normal development and craniosynostosis. In: Mao J, Nah D, eds. Craniofacial Growth and Development. New York: Blackwell Munksgund Publishing; (in press).
5. Morriss-Kay GM, Wilkie AO. Growth of the normal skull vault and its alteration in craniosynostosis: Insights from human genetics and experimental studies. J Anat. 2005;207:637-653. (Pubitemid 41723374)
6. Chatterjee JS, Mahmoud M, Karthikeyan S, et al. Referral pattern and surgical outcome of sagittal synostosis. J Plast Reconstr Aesthet Surg. 2009;62:211-215.
7. Esparza J, Hinojosa J. Complications in the surgical treatment of craniosynostosis and craniofacial syndromes: Apropos of 306 transcranial procedures. Childs Nerv Syst. 2008;24:1421-1430.
8. Esparza J, Hinojosa J, Garcia-Recuero I, et al. Surgical treatment of isolated and syndromic craniosynostosis. Results and complications in 283 consecutive cases. Neurocirugia (Astur). 2008;19:509-529.
9. Inagaki T, Kyutoku S, Seno T, et al. The intracranial pressure of the patients with mild form of craniosynostosis. Childs Nerv Syst. 2007;23:1455-1459. (Pubitemid 350142743)
10. Kelleher MO, Murray DJ, McGillivary A, et al. Non-syndromic trigonocephaly: Surgical decision making and long-term cosmetic results. Childs Nerv Syst. 2007;23:1285-1289. (Pubitemid 47456678)
11. Panchal J, Uttchin V. Management of craniosynostosis. Plast Reconstr Surg. 2003;111:2032-2048; quiz 2049. (Pubitemid 36532363)
12. Williams JK, Cohen SR, Burstein FD, et al. A longitudinal, statistical study of reoperation rates in craniosynostosis. Plast Reconstr Surg. 1997;100:305-310. (Pubitemid 27458762)
13. Williams MS. More on craniosynostosis. Pediatr Ann. 1997;26:711.
14. Levine JP, Bradley JP, Roth DA, et al. Studies in cranial suture biology: Regional dura mater determines overlying suture biology. Plast Reconstr Surg. 1998;101:1441-1447. (Pubitemid 28234646)
15. Most D, Levine JP, Chang J, et al. Studies in cranial suture biology: Up-regulation of transforming growth factor-beta1 and basic fibroblast growth factor mRNA correlates with posterior frontal cranial suture fusion in the rat. Plast Reconstr Surg. 1998;101:1431-1440. (Pubitemid 28234645)
16. Poisson E, Sciote JJ, Koepsel R, et al. Transforming growth factor-beta isoform expression in the perisutural tissues of craniosynostotic rabbits. Cleft Palate Craniofac J. 2004;41:392-402. (Pubitemid 38943974)
17. Shen Q, Zhu S, Hu J, et al. Recombinant human bone morphogenetic protein-4 (BMP-4)-stimulated cell differentiation and bone formation within the expanding calvarial suture in rats. J Craniofac Surg. 2009;20:1561-1565.
18. Maxson R, Ishii M. The BMP pathway in skull vault development. Front Oral Biol. 2008;12:197-208.
19. Springer IN, Warnke PH, Terheyden H, et al. Craniectomy and noggin application in an infant model. J Craniomaxillofac Surg. 2007;35:177-184. (Pubitemid 47029785)
20. Jacob S, Wu C, Freeman TA, et al. Expression of Indian hedgehog, BMP-4 and noggin in craniosynostosis induced by fetal constraint. Ann Plast Surg. 2007;58:215-221. (Pubitemid 46148636)
21. Cooper GM, Curry C, Barbano TE, et al. Noggin inhibits postoperative resynostosis in craniosynostotic rabbits. J Bone Miner Res. 2007;22:1046-1054. (Pubitemid 351339727)
22. Anderson RM, Stottmann RW, Choi M, et al. Endogenous bone morphogenetic protein antagonists regulate mammalian neural crest generation and survival. Dev Dyn. 2006;235:2507-2520. (Pubitemid 44325264)
23. Hannallah D, Peng H, Young B, et al. Retroviral delivery of noggin inhibits the formation of heterotopic ossification induced by BMP-4, demineralized bone matrix, and trauma in an animal model. J Bone Joint Surg Am. 2004;86-A:80-91. (Pubitemid 38057340)
24. Warren SM, Brunet LJ, Harland RM, et al. The BMP antagonist noggin regulates cranial suture fusion. Nature 2003;422:625-629. (Pubitemid 36460417)
25. Glaser DL, Economides AN, Wang L, et al. In vivo somatic cell gene transfer of an engineered noggin mutein prevents BMP4-induced heterotopic ossification. J Bone Joint Surg Am. 2003;85-A: 2332-2342. (Pubitemid 37499642)
26. Einhorn TA. Clinical applications of recombinant human BMPs: Early experience and future development. J Bone Joint Surg Am. 2003;85(Suppl 3):82-88. (Pubitemid 36957902)
27. Marie PJ, Debiais F, Hay E. Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling. Histol Histopathol. 2002;17:877-885. (Pubitemid 34784671)
28. Balemans W, Van Hul W. Extracellular regulation of BMP signaling in vertebrates: A cocktail of modulators. Dev Biol. 2002;250:231-250. (Pubitemid 35216412)
29. Yoshimura Y, Nomura S, Kawasaki S, et al. Colocalization of noggin and bone morphogenetic protein-4 during fracture healing. J Bone Miner Res. 2001;16:876-884. (Pubitemid 32332297)
30. Spector JA, Luchs JS, Mehrara BJ, et al. Expression of bone morphogenetic proteins during membranous bone healing. Plast Reconstr Surg. 2001;107:124-134. (Pubitemid 32039244)
31. Aspenberg P, Jeppsson C, Economides AN. The bone morphogenetic proteins antagonist noggin inhibits membranous ossification. J Bone Miner Res. 2001;16:497-500. (Pubitemid 32173364)
32. Onishi T, Ishidou Y, Nagamine T, et al. Distinct and overlapping patterns of localization of bone morphogenetic protein (BMP) family members and a BMP type II receptor during fracture healing in rats. Bone 1998;22:605-612. (Pubitemid 28284608)
33. McMahon JA, Takada S, Zimmerman LB, et al. Nogginmediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite. Genes Dev. 1998;12:1438-1452. (Pubitemid 28243629)
34. Kim HJ, Rice DP, Kettunen PJ, et al. FGF-, BMP-and Shhmediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development 1998;125:1241-1251. (Pubitemid 28203938)
35. Zegzula HD, Buck DC, Brekke J, et al. Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J Bone Joint Surg Am. 1997;79:1778-1790. (Pubitemid 28016582)
36. Zimmerman LB, De Jesus-Escobar JM, Harland RM. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 1996;86:599-606. (Pubitemid 26299491)
37. Cooper G, Lensie E, Cray J Jr, et al. BMP4 response in wild-type and craniosynostotic rabbit bone cells. Plast Reconstr Surg, 2010;125:1403-1411.
38. Caccamese J, Shand J, Sciote J, et al. Bone morphogenic protein expression in perisutural tissues of craniosynostotic rabbits. J Dent Res. 2004;83:2561.
39. Shand J, Sciote J, Cooper G, et al. Expression of bone morphogenetic proteins in the perisutural tissues in the craniosynostotic rabbit. J Dent Res. 2003;82:1B-371B.
40. Shand J, Sciote J, Mitchell R, et al. Localization of bone morphogenetic proteins (BMPs) in the the perisutural tissues of craniosynostotic rabbits. Int J Oral Maxillofac Surg. 2003;32:S26.
41. Mooney MP, Losken HW, Siegel MI, et al. Development of a strain of rabbits with congenital simple nonsyndromic coronal suture synostosis: Part II. Somatic and craniofacial growth patterns. Cleft Palate Craniofac J. 1994;31:8-16. (Pubitemid 24047550)
42. Mooney MP, Losken HW, Siegel MI, et al. Development of a strain of rabbits with congenital simple nonsyndromic coronal suture synostosis: Part I. Breeding demographics, inheritance pattern, and craniofacial anomalies. Cleft Palate Craniofac J. 1994;31:1-7. (Pubitemid 24047549)
43. Mooney MP, Smith TD, Burrows AM, et al. Coronal suture pathology and synostotic progression in rabbits with congenital craniosynostosis. Cleft Palate Craniofac J. 1996;33:369-378. (Pubitemid 26327789)
44. Mooney MP, Aston CE, Siegel MI, et al. Craniosynostosis with autosomal dominant transmission in New Zealand white rabbits. J Craniofac Genet Dev Biol. 1996;16:52-63. (Pubitemid 26055719)
45. Mooney MP, Siegel MI, Burrows AM, et al. A rabbit model of human familial, nonsyndromic unicoronal suture synostosis:. II. Intracranial contents, intracranial volume, and intracranial pressure. Childs Nerv Syst. 1998;14:247-255. (Pubitemid 28317413)
46. Mooney MP, Siegel MI, Burrows AM, et al. A rabbit model of human familial, nonsyndromic unicoronal suture synostosis: I. Synostotic onset, pathology, and sutural growth patterns. Childs Nerv Syst. 1998;14:236-246. (Pubitemid 28317412)
47. Burrows AM, Richtsmeier JT, Mooney MP, et al. Three-dimensional analysis of craniofacial form in a familial rabbit model of nonsyndromic coronal suture synostosis using Euclidean distance matrix analysis. Cleft Palate Craniofac J. 1999;36:196-206. (Pubitemid 29214858)
48. Hoffman HJ, Reddy KV. Progressive cranial suture stenosis in craniosynostosis. Neurosurg Clin North Am. 1991;2:555-564.
49. Losken HW, Mooney MP, Zoldos J, et al. Coronal suture response to distraction osteogenesis in rabbits with delayedonset craniosynostosis. J Craniofac Surg. 1999;10:27-37. (Pubitemid 29045883)
50. Losken HW, Mooney MP, Zoldos J, et al. Internal calvarial bone distraction in rabbits with delayed-onset coronal suture synostosis. Plast Reconstr Surg. 1998;102:1109-1119; discussion 1120-1121. (Pubitemid 128723397)
51. Reddy K, Hoffman H, Armstrong D. Delayed and progressive multiple suture craniosynostosis. Neurosurgery 1990;26:442-448. (Pubitemid 20092858)
52. Chong SL, Mitchell R, Moursi AM, et al. Rescue of coronal suture fusion using transforming growth factor-beta 3 (Tgfbeta 3) in rabbits with delayed-onset craniosynostosis. Anat Rec. 2003;274:962-971. (Pubitemid 37267780)
53. Mooney MP, Losken HW, Moursi AM, et al. Anti-TGF-beta2 antibody therapy inhibits postoperative resynostosis in craniosynostotic rabbits. Plast Reconstr Surg. 2007;119:1200-1212; discussion 1213-1215. (Pubitemid 46673577)
54. Mooney MP, Losken HW, Moursi AM, et al. Postoperative anti-Tgf-beta2 antibody therapy improves intracranial volume and craniofacial growth in craniosynostotic rabbits. J Craniofac Surg. 2007;18:336-346; discussion 347-349. (Pubitemid 46597502)
55. Burrows AM, Mooney MP, Smith TD, et al. Growth of the cranial vault in rabbits with congenital coronal suture synostosis. Cleft Palate Craniofac J. 1995;32:235-246.
56. Gabbay JS, Heller J, Spoon DB, et al. Noggin underexpression and runx-2 overexpression in a craniosynostosis rabbit model. Ann Plast Surg. 2006;56:306-311.
57. Greenwald JA, Mehrara BJ, Spector JA, et al. In vivo modulation of FGF biological activity alters cranial suture fate. Am J Pathol. 2001;158:441-452. (Pubitemid 32158607)
58. Kwan MD, Wan DC, Wang Z, et al. Microarray analysis of the role of regional dura mater in cranial suture fate. Plast Reconstr Surg. 2008;122:389-399.
59. Connerney J, Andreeva V, Leshem Y, et al. Twist1 homodimers enhance FGF responsiveness of the cranial sutures and promote suture closure. Dev Biol. 2008;318:323-334.
60. Marie PJ, Kaabeche K, Guenou H. Roles of FGFR2 and twist in human craniosynostosis: Insights from genetic mutations in cranial osteoblasts. Front Oral Biol. 2008;12:144-159.
61. Coussens AK, Hughes IP, Wilkinson CR, et al. Identification of genes differentially expressed by prematurely fused human sutures using a novel in vivo-in vitro approach. Differentiation 2008;76:531-545. (Pubitemid 351725834)
62. Coussens AK, Wilkinson CR, Hughes IP, et al. Unravelling the molecular control of calvarial suture fusion in children with craniosynostosis. BMC Genomics 2007;8:458.
63. Carinci P, Becchetti E, Baroni T, et al. Extracellular matrix and growth factors in the pathogenesis of some craniofacial malformations. Eur J Histochem. 2007;1(Suppl. 51):105-115.
64. Merrill AE, Bochukova EG, Brugger SM, et al. Cell mixing at a neural crest-mesoderm boundary and deficient ephrin-Eph signaling in the pathogenesis of craniosynostosis. Hum Mol Genet. 2006;15:1319-1328.
65. Opperman LA, Ogle RC. Molecular studies of craniosynostosis: Factors affecting cranial suture morphogenesis and patency. In: Mooney MP, Siegel MI, eds. Understanding Craniofacial Anomalies: The Etiopathogenesis of Craniosynostosis and Facial Clefting. New York: John Wiley and Sons; 2002:497-518.
66. Shen K, Krakora SM, Cunningham M, et al. Medical treatment of craniosynostosis: Recombinant noggin inhibits coronal suture closure in the rat craniosynostosis model. Orthod Craniofac Res. 2009;12:254-262.
67. Premaraj S, Mundy BL, Morgan D, et al. Sustained delivery of bioactive cytokine using a dense collagen gel vehicle collagen gel delivery of bioactive cytokine. Arch Oral Biol. 2006;51:325-333. (Pubitemid 43363508)
68. Aviv RI, Rodger E, Hall CM. Craniosynostosis. Clin Radiol. 2002;57:93-102.
69. Boyadjiev SA. Genetic analysis of non-syndromic craniosynostosis. Orthod Craniofac Res. 2007;10:129-137.
70. Horutz K, Etzel K, Owens M, et al. In situ analysis of Msx2 expression in craniosynostotic rabbits. J Dent Res. 1996;75:120.